Author

Tijana Martinov

Fred Hutch Cancer CenterORCID 0000-0002-6027-3380Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Philip D. GreenbergiD· 2 shared Shwetha Mureli· 2 shared Alexander MarsoniD· 1 shared Angie Vazquez· 1 shared Ashley M. TheleniD· 1 shared Aude G. ChapuisiD· 1 shared Brian Rudolph ShyiD· 1 shared Camille FouassieriD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Philip D. GreenbergORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy

Sasha Gupta, Tijana Martinov, Ashley M. Thelen, Megumi Sunahara, Shwetha Mureli, Angie Vazquez, Josiah Gerdts, Ravi Dandekar, Irene C. M. Cortese, Camille Fouassier, Elaine V. Schanzer, Fyodor D. Urnov, Alexander Marson, Brian Rudolph Shy, Philip D. Greenberg, Michael R. Wilson

The paper identifies JCV VP1 epitopes recognized by HLA-A2 and isolates TCRs that recognize these epitopes, showing cytotoxic activity against infected cells.

bioRxiv · Nov 4, 2024 · PreprintNeuroscience

Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity

Jihoon William Lee, Emily Y. Chen, Taylor Hu, Rachel Perret, Mary E. Chaffee, Tijana Martinov, Shwetha Mureli, Clara McCurdy, Lisa Anne Jones, Philip R. Gafken, Pritha Chanana, Yapeng Su, Aude G. Chapuis, Philip H Bradley, Thomas M. Schmitt, Philip D. Greenberg

Tumor cell methylation of KRASG12V epitope in HLA-A2 permits immune evasion, and new TCRs were generated to overcome this with engineered cell therapy.

bioRxiv · Sep 18, 2024 · PreprintImmunology